Literature DB >> 24077438

Effect of dexamethasone administered with magnesium sulfate on inflammation-mediated degradation of the blood-brain barrier using an in vitro model.

Monica A Lutgendorf1, Danielle L Ippolito, Mariano T Mesngon, Deborah Tinnemore, Mary Jo Dehart, Brad M Dolinsky, Peter G Napolitano.   

Abstract

Patients at risk for preterm delivery are frequently administered both antenatal steroids for fetal maturation and magnesium sulfate for neuroprotection. In this study, we investigate whether steroids coadministered with magnesium sulfate preserve blood-brain barrier integrity in neuroinflammation. Human umbilical vein endothelial cells were grown in astroglial conditioned media in a 2-chamber cell culture apparatus. Treatment with tumor necrosis factor-α (TNF-α) or catalytically active recombinant matrix metalloproteinase 9 (MMP-9) simulated neuroinflammation. Membrane integrity was assessed by zona occludens 1 (ZO-1) immunoreactivity, permeability to fluorescently conjugated dextran, and transendothelial electrical resistance (TEER). The TNF-α and MMP-9 treatment increased the rate of dextran transit, decreased TEER, and decreased ZO-1 immunoreactivity at junctional interfaces. Dexamethasone pretreatment alone or in combination with 0.5 mmol/L magnesium sulfate preserved monolayer integrity after inflammatory insult. Magnesium sulfate alone was not protective. This study supports a possible interaction between steroids and magnesium in neuroprotection.

Entities:  

Keywords:  magnesium; matrix metalloproteinase 9; neuroprotection

Mesh:

Substances:

Year:  2013        PMID: 24077438      PMCID: PMC3960840          DOI: 10.1177/1933719113503410

Source DB:  PubMed          Journal:  Reprod Sci        ISSN: 1933-7191            Impact factor:   3.060


  57 in total

1.  Antenatal glucocorticoid treatment and cystic periventricular leukomalacia in very premature infants.

Authors:  O Baud; L Foix-L'Helias; M Kaminski; F Audibert; P H Jarreau; E Papiernik; C Huon; J Lepercq; M Dehan; T Lacaze-Masmonteil
Journal:  N Engl J Med       Date:  1999-10-14       Impact factor: 91.245

2.  In vitro model for evaluating drug transport across the blood-brain barrier.

Authors: 
Journal:  Adv Drug Deliv Rev       Date:  1999-04-05       Impact factor: 15.470

3.  Association of cord blood magnesium concentration and neonatal resuscitation.

Authors:  Lynn H Johnson; Delicia C Mapp; Dwight J Rouse; Catherine Y Spong; Brian M Mercer; Kenneth J Leveno; Michael W Varner; Jay D Iams; Yoram Sorokin; Susan M Ramin; Menachem Miodovnik; Mary J O'Sullivan; Alan M Peaceman; Steve N Caritis
Journal:  J Pediatr       Date:  2011-11-04       Impact factor: 4.406

4.  Fetal exposure to an intra-amniotic inflammation and the development of cerebral palsy at the age of three years.

Authors:  B H Yoon; R Romero; J S Park; C J Kim; S H Kim; J H Choi; T R Han
Journal:  Am J Obstet Gynecol       Date:  2000-03       Impact factor: 8.661

Review 5.  Chorioamnionitis as a risk factor for cerebral palsy: A meta-analysis.

Authors:  Y W Wu; J M Colford
Journal:  JAMA       Date:  2000-09-20       Impact factor: 56.272

6.  Magnesium sulfate suppresses inflammatory responses by human umbilical vein endothelial cells (HuVECs) through the NFkappaB pathway.

Authors:  Burton Rochelson; Oonagh Dowling; Nadav Schwartz; Christine N Metz
Journal:  J Reprod Immunol       Date:  2006-09-06       Impact factor: 4.054

Review 7.  The matrix metalloproteinases (MMPS) in the decidua and fetal membranes.

Authors:  Amir Weiss; Shlomit Goldman; Eliezer Shalev
Journal:  Front Biosci       Date:  2007-01-01

8.  Magnesium sulphate given before very-preterm birth to protect infant brain: the randomised controlled PREMAG trial*.

Authors:  S Marret; L Marpeau; V Zupan-Simunek; D Eurin; C Lévêque; M-F Hellot; J Bénichou
Journal:  BJOG       Date:  2006-12-04       Impact factor: 6.531

9.  A randomized, controlled trial of magnesium sulfate for the prevention of cerebral palsy.

Authors:  Dwight J Rouse; Deborah G Hirtz; Elizabeth Thom; Michael W Varner; Catherine Y Spong; Brian M Mercer; Jay D Iams; Ronald J Wapner; Yoram Sorokin; James M Alexander; Margaret Harper; John M Thorp; Susan M Ramin; Fergal D Malone; Marshall Carpenter; Menachem Miodovnik; Atef Moawad; Mary J O'Sullivan; Alan M Peaceman; Gary D V Hankins; Oded Langer; Steve N Caritis; James M Roberts
Journal:  N Engl J Med       Date:  2008-08-28       Impact factor: 91.245

Review 10.  Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus.

Authors:  Lex W Doyle; Caroline A Crowther; Philippa Middleton; Stephane Marret; Dwight Rouse
Journal:  Cochrane Database Syst Rev       Date:  2009-01-21
View more
  4 in total

1.  Blood brain barrier (BBB)-disruption in intracortical silicon microelectrode implants.

Authors:  Cassie Bennett; Malaroviyam Samikkannu; Farrah Mohammed; W Dalton Dietrich; Suhrud M Rajguru; Abhishek Prasad
Journal:  Biomaterials       Date:  2018-02-20       Impact factor: 12.479

2.  LDL-lipids from patients with hypercholesterolaemia and Alzheimer's disease are inflammatory to microvascular endothelial cells: mitigation by statin intervention.

Authors:  H K Irundika Dias; Caroline L R Brown; M Cristina Polidori; Gregory Y H Lip; Helen R Griffiths
Journal:  Clin Sci (Lond)       Date:  2015-09-23       Impact factor: 6.124

3.  Permeability across a novel microfluidic blood-tumor barrier model.

Authors:  Tori B Terrell-Hall; Amanda G Ammer; Jessica I G Griffith; Paul R Lockman
Journal:  Fluids Barriers CNS       Date:  2017-01-23

4.  Implementation of an antenatal magnesium sulfate protocol for fetal neuroprotection in preterm infants.

Authors:  Pierre-Emmanuel Bouet; Stéphanie Brun; Hugo Madar; Anne-Laure Baisson; Véronique Courtay; Géraldine Gascoin-Lachambre; Sigismond Lasocki; Loïc Sentilhes
Journal:  Sci Rep       Date:  2015-09-29       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.